secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2021-12-22T23:59:59+00:00
Accession:  0001193125-21-365119
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya Therapeutics appoints Karah Parschauer to Board and Joanna Auch as SVP of People and Culture
--------------------------------------------------------------------------------

- Board expanded to 10 members; Karah Parschauer appointed as Class I director and audit committee member.
- Parschauer receives $35k annual cash retainer, $7.5k audit committee retainer, and ~$320k stock option grant.
- Joanna Auch appointed as SVP of People and Culture; previously Head of HR North America at Santen.
- Both appointments effective December 22, 2021; Parschauer's term expires at 2022 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000119312521365119/0001193125-21-365119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000119312521365119/d263572d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-365119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer